Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 34724529.
- Also identified by DOI 10.1001/jama.2021.19996 and PMC identifier 8561429.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study examines antibody durability in individuals who received an mRNA SARS-CoV-2 vaccine with prior SARS-CoV-2 infection vs those without infection.
Medical subject headings
- COVID-19
- COVID-19 Vaccines
- Immunoglobulin G
- Spike Glycoprotein, Coronavirus